TORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificates19-07-2023
19-07-2023
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
We hereby inform that the Company has scheduled a teleconference with Investors / Analyst on 7th August, 2023 at 06:00 P.M. to discuss the financial performance of the Company for the quarter ended 30th June, 2023.19-07-2023
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith the copies of Newspaper cuttings published in Financial Express (English & Gujarati) on 15th July, 2023 in connection with the 50th Annual General Meeting and E-Voting Procedure.15-07-2023
TORRENT PHARMACEUTICALS LTD. - 500420 - Board Meeting Intimation for Intimation Of The Date Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2023 ,inter alia, to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter ended on 30-Jun-23.15-07-2023
TORRENT PHARMACEUTICALS LTD. - 500420 - Submission Of The Annual Report For The FY 2022-23 And The Notice Convening 50Th Annual General Meeting Of The Company.
Submission of the Annual Report for the FY 2022-23 and the notice convening 50th Annual General Meeting of the Company14-07-2023
TORRENT PHARMACEUTICALS LTD. - 500420 - Business Responsibility and Sustainability Reporting (BRSR)
Pursuant to Regulation 34(2)(f) of SEBI Listing Regulations, please find enclosed herewith Business Responsibility and Sustainability Report (BRSR) for the FY 2022-2314-07-2023
TORRENT PHARMACEUTICALS LTD. - 500420 - Reg. 34 (1) Annual Report.
Please find attached herewith soft copy of the Integrated Annual Report 2022-23 (comprising of Notice calling 50th Annual General Meeting (AGM) along with Audited Financial Statements, Directors'' Report, Auditors' Report, etc.) of Torrent Pharmaceuticals Limited ("the Company") in compliance with Regulation 34(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the Listing Regulations'). The above is for your information and record.14-07-2023
Torrent Pharma Q1 PAT may dip 9.7% YoY to Rs 319.7 cr: Nirmal Bang
Net Sales are expected to increase by 11 percent Y-o-Y (up 4.6 percent Q-o-Q) to Rs 2,604.6 crore, according to Nirmal Bang.12-07-2023
TORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of issue of Duplicate Share Certificates07-07-2023
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement - Intimation of the 50th Annual General Meeting of the Company through Video-Conferencing / Other Audio Visual Means ("VC / OAVM") facility.06-07-2023